| 臺大學術典藏 |
2020-06-29T01:39:40Z |
Impulsivity in Cerebellar Ataxias: Testing the Cerebellar Reward Hypothesis in Humans
|
Amokrane N.;Viswanathan A.;Freedman S.;Yang C.-Y.;Desai N.A.;Ming-Kai Pan;Kuo S.-H.;Lin C.-Y.; Amokrane N.; Viswanathan A.; Freedman S.; Yang C.-Y.; Desai N.A.; MING-KAI PAN; Kuo S.-H.; Lin C.-Y. |
| 臺大學術典藏 |
2020-06-19T02:38:42Z |
Evaluation of yellow IRIS/model 450 for routine urinalysis
|
Huang L.Y.;Hsieh S.W.;Ya-Chien Yang;Kuo S.H.; Huang L.Y.; Hsieh S.W.; YA-CHIEN YANG; Kuo S.H. |
| 臺大學術典藏 |
2020-06-16T07:53:43Z |
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy
|
Kuo S.-H.;Liang-In Lin;Chang C.-J.;Liu Y.-R.;Lin K.-S.;Cheng A.-L.; Kuo S.-H.; LIANG-IN LIN; Chang C.-J.; Liu Y.-R.; Lin K.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-06-03T08:10:43Z |
Panhypopituitarism caused by solitary parasellar metastasis from lung cancer
|
Ko J.-C.; Yang P.-C.; TIEN-SHANG HUANG; Yeh K.-H.; Kuo S.-H.; Luh K.T.; Ko J.-C.;Yang P.-C.;Tien-Shang Huang;Yeh K.-H.;Kuo S.-H.;Luh K.T. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H;Chih-Hsin Yang;Yu C.-J;Hsu C;Cheng A.-L;Yang P.-C.; Kuo S.-H; CHIH-HSIN YANG; Yu C.-J; Hsu C; Cheng A.-L; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:29Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Lu Y.-S;Hsu C;Li C.-C;Kuo S.-H;Yeh K.-H;Chih-Hsin Yang;Hsu C.-H;Wu C.-Y;Cheng A.-L.; Lu Y.-S; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; CHIH-HSIN YANG; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-26T09:27:24Z |
Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response
|
Yang P.-C.;Chih-Hsin Yang;Yu C.-J;Chang Y.-C;Shih J.-Y;Kuo S.-H;Chiu Y.-H;Chang Y.-L;Chien C.-R;Gow C.-H; Gow C.-H; Chien C.-R; Chang Y.-L; Chiu Y.-H; Kuo S.-H; Shih J.-Y; Chang Y.-C; Yu C.-J; CHIH-HSIN YANG; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:21Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Lin C.-C; Huang T.-C; Yang P.-C; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Cheng A.-L; Hu F.-C; Kuo S.-H; Hsu C; Chih-Hsin Yang;Yang P.-C;Huang T.-C;Lin C.-C;Yu C.-J;Shih J.-Y;Cheng A.-L;Hu F.-C;Kuo S.-H;Hsu C |
| 臺大學術典藏 |
2020-05-26T09:26:54Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; Lu Y.-S; Cheng A.-L.; Cheng A.-L.;Lu Y.-S;Chen C.-J;Kuo S.-H;Wu P.-F;Chen I.-C;Chen W.-W;Kuo K.-T;Hsiung C.-N;Chang D.-Y;Kuo W.-H;Chih-Hsin Yang;Huang C.-S;Lee J.-H;Shen C.-Y;Lin C.-H; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; CHIH-HSIN YANG; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W |
| 臺大學術典藏 |
2020-05-26T09:26:51Z |
The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases
|
Kuo S.-H.;Cheng A.-L;Lan K.-H;Lin Z.-Z;Shih J.-Y;Chen Y.-H;Hsu F.-M;Chih-Hsin Yang;Chiang Y; Chiang Y; CHIH-HSIN YANG; Hsu F.-M; Chen Y.-H; Shih J.-Y; Lin Z.-Z; Lan K.-H; Cheng A.-L; Kuo S.-H. |
| 臺大學術典藏 |
2020-05-25T07:45:55Z |
Human herpesvirus-8 associated Kaposi's sarcoma after lung transplantation: A case report
|
Pei-Ming Huang;Chang Y.-L.;Chen J.-S.;Hsu H.-H.;Ko W.-J.;Kuo S.-H.;Lee Y.-C.; PEI-MING HUANG; Chang Y.-L.; Chen J.-S.; Hsu H.-H.; Ko W.-J.; Kuo S.-H.; Lee Y.-C. |
| 臺大學術典藏 |
2020-05-25T07:35:30Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Hsu C; Kuo S.-H; Hu F.-C; Cheng A.-L; Shih J.-Y; Yu C.-J; Chia-Chi Lin; Huang T.-C; Yang P.-C; Yang C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:10Z |
A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma
|
Yang S.-H; Shao Y.-Y; Chia-Chi Lin; Kuo S.-H; Cheng A.-L; Yeh K.-H. |
| 臺大學術典藏 |
2020-05-25T07:32:50Z |
Human herpesvirus-8 associated Kaposi's sarcoma after lung transplantation: A case report
|
Lee Y.-C.; Kuo S.-H.; Ko W.-J.; Hsu H.-H.; Chen J.-S.; Chang Y.-L.; PEI-MING HUANG |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Recent advances in the management of primary breast cancers
|
Huang C.-S.;Kuo S.-H;Yen-Shen Lu; YEN-SHEN LU; Kuo S.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
Phase II study of combination doxorubicin, interferon-�\, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Cheng A.-L.;Wu C.-Y;Hsu C.-H;Yang C.-H;Yeh K.-H;Kuo S.-H;Li C.-C;Hsu C;Yen-Shen Lu; YEN-SHEN LU; Hsu C; Li C.-C; Kuo S.-H; Yeh K.-H; Yang C.-H; Hsu C.-H; Wu C.-Y; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:09Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh K.-H;Yen-Shen Lu;Hsu C.-H;Lin J.-F;Hsu C;Kuo S.-H;Li Jr. S;Cheng A.-L.; Yeh K.-H; YEN-SHEN LU; Hsu C.-H; Lin J.-F; Hsu C; Kuo S.-H; Li Jr. S; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:08Z |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors
|
Kuo M.-L; Kuo S.-H; Cheng A.-L.; Yeh K.-H; Yeh P.-Y; Lien H.-C; YEN-SHEN LU; Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Yeh K.-H;Kuo M.-L;Kuo S.-H;Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:07Z |
Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity
|
Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Kuo S.-H;Chang W.-C;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Lien H.-C; Yeh P.-Y; Kuo S.-H; Chang W.-C; Kuo M.-L; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:06Z |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients
|
Huang C.-S.;Chen T.-Z;Lin C.-H;Yen-Shen Lu;You S.-L;Lien H.-C;Kuo S.-H; Kuo S.-H; Lien H.-C; You S.-L; YEN-SHEN LU; Lin C.-H; Chen T.-Z; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:52:05Z |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
|
Chang K.-J.;Yen-Shen Lu;Lin C.-H;Shen C.-Y;You S.-L;Yang S.-Y;Lien H.-C;Kuo S.-H;Huang C.-S; Huang C.-S; Kuo S.-H; Lien H.-C; Yang S.-Y; You S.-L; Shen C.-Y; Lin C.-H; YEN-SHEN LU; Chang K.-J. |
| 臺大學術典藏 |
2020-05-25T06:52:04Z |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
Cheng A.-L.;Chang K.-J;Kuo W.-H;Liu J.M;Lan C;Kuo S.-H;Shen Y.-C;Kuo K.-T;Lee W.-C;Huang C.-S;Yen-Shen Lu;Liau J.-Y;Lin C.-H; Lin C.-H; Liau J.-Y; YEN-SHEN LU; Huang C.-S; Lee W.-C; Kuo K.-T; Shen Y.-C; Kuo S.-H; Lan C; Liu J.M; Kuo W.-H; Chang K.-J; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:01Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H;Hsu C.-H;Chen L.-T;Yen-Shen Lu;Lin C.-H;Yeh P.-Y;Jeng H.-J;Gao M;Yeh K.-H;Cheng A.-L.; Kuo S.-H; Hsu C.-H; Chen L.-T; YEN-SHEN LU; Lin C.-H; Yeh P.-Y; Jeng H.-J; Gao M; Yeh K.-H; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:52:00Z |
Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
|
Yen-Shen Lu;Chen D.-R;Tseng L.-M;Yeh D.-C;Chen S.-T;Hsieh C.-M;Wang H.-C;Yeh H.-T;Kuo S.-H;Huang C.-S.; YEN-SHEN LU; Chen D.-R; Tseng L.-M; Yeh D.-C; Chen S.-T; Hsieh C.-M; Wang H.-C; Yeh H.-T; Kuo S.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:55Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo S.-H;Yang S.-Y;Lien H.-C;Lo C;Lin C.-H;Yen-Shen Lu;Cheng A.-L;Chang K.-J;Huang C.-S.; Kuo S.-H; Yang S.-Y; Lien H.-C; Lo C; Lin C.-H; YEN-SHEN LU; Cheng A.-L; Chang K.-J; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:53Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H;Shen C.-Y;Lee J.-H;Huang C.-S;Yang C.-H;Kuo W.-H;Chang D.-Y;Hsiung C.-N;Kuo K.-T;Chen W.-W;Chen I.-C;Wu P.-F;Kuo S.-H;Chen C.-J;Yen-Shen Lu;Cheng A.-L.; Lin C.-H; Shen C.-Y; Lee J.-H; Huang C.-S; Yang C.-H; Kuo W.-H; Chang D.-Y; Hsiung C.-N; Kuo K.-T; Chen W.-W; Chen I.-C; Wu P.-F; Kuo S.-H; Chen C.-J; YEN-SHEN LU; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:51Z |
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer
|
Lin P.-H;Kuo W.-H;Huang A.-C;Yen-Shen Lu;Lin C.-H;Kuo S.-H;Wang M.-Y;Liu C.-Y;Cheng F.T.-F;Yeh M.-H;Li H.-Y;Yang Y.-H;Hsu Y.-H;Fan S.-C;Li L.-Y;Yu S.-L;Chang K.-J;Chen P.-L;Ni Y.-H;Huang C.-S.; Lin P.-H; Kuo W.-H; Huang A.-C; YEN-SHEN LU; Lin C.-H; Kuo S.-H; Wang M.-Y; Liu C.-Y; Cheng F.T.-F; Yeh M.-H; Li H.-Y; Yang Y.-H; Hsu Y.-H; Fan S.-C; Li L.-Y; Yu S.-L; Chang K.-J; Chen P.-L; Ni Y.-H; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T06:51:49Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai S.-F;Chen Y.-H;Kuo W.-H;Lien H.-C;Wang M.-Y;Yen-Shen Lu;Lo C;Kuo S.-H;Cheng A.-L;Huang C.-S.; Lai S.-F; Chen Y.-H; Kuo W.-H; Lien H.-C; Wang M.-Y; YEN-SHEN LU; Lo C; Kuo S.-H; Cheng A.-L; Huang C.-S. |
| 臺大學術典藏 |
2020-05-25T02:45:35Z |
The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases
|
Chiang Y; Yang J.C.-H; Feng-Ming Hsu; Chen Y.-H; Shih J.-Y; Lin Z.-Z; Lan K.-H; Cheng A.-L; Kuo S.-H. |
| 臺大學術典藏 |
2020-05-25T02:45:29Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C;Xiao F;Shih J.-Y;Ho C.-C;Chen Y.-F;Tseng H.-M;Chen K.-Y;Liao W.-Y;Yu C.-J;Yang J.C.-H;Kuo S.-H;Cheng J.C.-H;Yang P.-C;Feng-Ming Hsu; Yang W.-C; Xiao F; Shih J.-Y; Ho C.-C; Chen Y.-F; Tseng H.-M; Chen K.-Y; Liao W.-Y; Yu C.-J; Yang J.C.-H; Kuo S.-H; Cheng J.C.-H; Yang P.-C; Feng-Ming Hsu |
| 臺大學術典藏 |
2020-05-18T08:39:07Z |
Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients
|
Hsu H.-N.;Chen J.-S.;Kuo S.-H.;Chiang F.-T.;Ko W.-J.;Shuenn-Wen Kuo;Huang S.-C.;Lee Y.-C.; Hsu H.-N.; Chen J.-S.; Kuo S.-H.; Chiang F.-T.; Ko W.-J.; SHUENN-WEN KUO; Huang S.-C.; Lee Y.-C. |
| 臺大學術典藏 |
2020-05-14T06:59:51Z |
New Method to avoid End-effects on the Wake of Circular Cylinder at Low Reynolds Numbers
|
Wang, A.-B.; Wang, H.-C.; Kuo, S.-H.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-14T06:59:15Z |
New Method to avoid End-effects on the Wake of Circular Cylinder at Low Reynolds Numbers
|
Wang, A.-B.; Wang, H.-C.; Kuo, S.-H.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-14T06:59:14Z |
New Method to avoid End-effects on the Wake of Circular Cylinder at Low Reynolds Numbers
|
Kuo, S.-H.; Wang, A.-B.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-14T06:59:07Z |
A New Method to Generate Parallel Vortex Shedding from a Circular Cylinder in the Laminar Range with Less Side-effects
|
Wang, A.-B.; Kuo, S.-H.; Trávnícek, Z.; Hwang, Y.-S.; AN-BANG WANG |
| 臺大學術典藏 |
2020-04-28T07:25:37Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
CHIH-HUNG HSU; Wu C.-Y.; Cheng A.-L.; Lu Y.-S.;Hsu C.;Li C.-C.;Kuo S.-H.;Yeh K.-H.;Yang C.-H.;Chih-Hung Hsu;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:35Z |
Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer
|
Yeh K.-H.;Lu Y.-S.;Chih-Hung Hsu;Lin J.-F.;Hsu C.;Kuo S.-H.;Li Jr. S.;Cheng A.-L.; Yeh K.-H.; Lu Y.-S.; CHIH-HUNG HSU; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus
|
Pei Y.Y.;Kuo S.-H.;Yeh K.-H.;Chuang S.-E.;Chih-Hung Hsu;Wen C.C.;Lin H.-I.;Gao M.;Cheng A.-L.; Pei Y.Y.; Kuo S.-H.; Yeh K.-H.; Chuang S.-E.; CHIH-HUNG HSU; Wen C.C.; Lin H.-I.; Gao M.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:27Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Kuo S.-H.;Chih-Hung Hsu;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; CHIH-HUNG HSU; Lu Y.-S.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:26Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H.; CHIH-HUNG HSU; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H. ;Chih-Hung Hsu ;Chen L.-T. ;Lu Y.-S. ;Lin C.-H. ;Yeh P.-Y. ;Jeng H.-J. ;Gao M. ;Yeh K.-H. ;Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
Yang S.-H. ;Kuo Y.-H. ;Tien Y.-W. ;Hsu C. ;Chih-Hung Hsu ;Kuo S.-H. ;Cheng A.-L.; Yang S.-H.; Kuo Y.-H.; Tien Y.-W.; Hsu C.; CHIH-HUNG HSU; Kuo S.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo S.-H. ;Cheng A.-L. ;Lin C.-W. ;Chih-Hung Hsu ;Wu M.-S. ;Yeh K.-H. ;Tzeng Y.-S. ;Chen L.-T.; Kuo S.-H.; Cheng A.-L.; Lin C.-W.; CHIH-HUNG HSU; Wu M.-S.; Yeh K.-H.; Tzeng Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2020-04-27T08:45:11Z |
Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase?1 inhibition [Strahlenempfindlichkeit beim ?sophagealen Plattenepithelkarzinom: Wirksamkeit des Polo-like-Kinase-1-Inhibitors]
|
CHIA-HSIEN CHENG; Kuo S.-H.; Shieh M.-J.; Huang Y.-S.; Chen J.-P.; Chen J.L.-Y.;Chen J.-P.;Huang Y.-S.;Tsai Y.-C.;Tsai M.-H.;Jaw F.-S.;Chia-Hsien Cheng;Kuo S.-H.;Shieh M.-J.; Chen J.L.-Y.; Jaw F.-S.; Tsai Y.-C.; Tsai M.-H. |
| 臺大學術典藏 |
2020-04-27T08:45:08Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Chia-Hsien Cheng;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; CHIA-HSIEN CHENG; Yang P.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2020-04-27T08:45:06Z |
Local Control and Clinical Outcome of High-risk Pediatric Neuroblastoma Patients after Receiving Multimodality Treatment and Helical Tomotherapy
|
Chen G.-Y.;Chia-Hsien Cheng;Chen Y.-H.;Lu M.-Y.;Chang H.-H.;Yang Y.-L.;Jou S.-T.;Hsu W.-M.;Kuo S.-H.; Chen G.-Y.; CHIA-HSIEN CHENG; Chen Y.-H.; Lu M.-Y.; Chang H.-H.; Yang Y.-L.; Jou S.-T.; Hsu W.-M.; Kuo S.-H. |
| 臺大學術典藏 |
2020-04-10T12:51:29Z |
Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma
|
Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; Cheng A.-L.; Lu Y.-S.;Chiun Hsu;Li C.-C.;Kuo S.-H.;Yeh K.-H.;Yang C.-H.;Hsu C.-H.;Wu C.-Y.;Cheng A.-L.; Lu Y.-S.; Chiun Hsu |
| 臺大學術典藏 |
2020-04-10T12:51:28Z |
Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials
|
Kuo S.-H.;Yang C.-H.;Yu C.-J.;Chiun Hsu;Cheng A.-L.;Yang P.-C.; Kuo S.-H.; Yang C.-H.; Yu C.-J.; Chiun Hsu; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2020-04-10T12:51:22Z |
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
|
Huang T.-C.; Yang P.-C.; Yang C.-H.; Lin C.-C.; Chiun Hsu; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-04-10T12:51:21Z |
The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma
|
Lin Z.-Z.;Hsu H.-C.;Hsu C.-H.;Yeh P.-Y.;Huang C.-Y.F.;Huang Y.-F.;Chen T.-J.;Kuo S.-H.;Chiun Hsu;Hu F.-C.;Jeng Y.-M.;Chung Y.;Cheng A.-L.; Lin Z.-Z.; Hsu H.-C.; Hsu C.-H.; Yeh P.-Y.; Huang C.-Y.F.; Huang Y.-F.; Chen T.-J.; Kuo S.-H.; Chiun Hsu; Hu F.-C.; Jeng Y.-M.; Chung Y.; Cheng A.-L. |
